Endocyte Inc. | Key People and Executives
Michael A. Sherman
President, Chief Executive Officer & Director
Philip S. Low
Director & Chief Science Officer
John C. Aplin
Non-Executive Chairman
Lesley Russell
Independent Director
Clarence Patrick Machado
Independent Director
Colin Goddard
Independent Director
Fred A. Middleton
Independent Director
Marc D. Kozin
Independent Director
Michael A. Sherman
President, Chief Executive Officer & Director
Michael T. Andriole
Chief Financial Officer
Alison A. Armour
Chief Medical Officer
Philip S. Low
Director & Chief Science Officer
Christopher P. Leamon
Vice President-Research & Development
Erik C. Chelius
Vice President-CMC Division
Iontcho Vlahov
Vice President-Discovery Chemistry
Matthew A. Call
Vice President-Business Development & Marketing
Beth A. Taylor
Chief Accounting Officer & Vice President-Finance
Katherine K. Parker
Vice President-Human Resources
Daniel L. Boeglin
Secretary
Scot L. Harper
Vice President-Clinical Operations
John C. Aplin
Non-Executive Chairman
Lesley Russell
Independent Director
Clarence Patrick Machado
Independent Director
Colin Goddard
Independent Director
Fred A. Middleton
Independent Director
Marc D. Kozin
Independent Director
| Address |
3000 Kent Avenue
West Lafayette Indiana 47906
United States
|
|
Employees
|
- |
| Website |
http://www.endocyte.com |
| Updated |
09/14/2018 |
| Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. |
